Alexander Blostein

BATS Global Markets, Inc. (BATS: BATS) is the lowest-cost provider in trading, on account of its technology and scale. Goldman Sachs’ Alexander Blostein initiated coverage of the company with a Neutral rating and a price target of $25. The analyst commented that while BATS has market share...

Goldman Sachs’ Alexander Blostein maintained a Buy rating on Affiliated Managers Group, Inc. (NYSE: AMG), while raising the price target from $175 to $190. Return Potential Adding the stock to Goldman Sachs’ America's Conviction List, Blostein mentioned that the stock has 19 percent...

In a report published Friday, Goldman Sachs analyst Alexander Blostein commented that he expects Asset Managers to report "soft results" and deteriorating organic growth for most firms. Blostein noted that U.S. equities represent a large source of outflows with $53 billion rotated out of domestic...

In a report published Friday, Goldman Sachs analyst Alexander Blostein downgraded shares of TD Ameritrade Holding Corp. (NYSE: AMTD) to Neutral from Buy despite "lots of earnings per share upside." Blostein noted that shares of TD Ameritrade are trading near his $38 per share price...

E TRADE Financial Corporation (NASDAQ: ETFC) shares got oversold in the recent market meltdown and now might offer investors a 24 percent upside, an analyst said Monday. The online trading company is down nearly 14 percent since market highs in September. It's expected to post earnings...

In a report published Friday, Goldman Sachs analyst Alexander Blostein upgraded the rating on E*TRADE Financial Corporation (NASDAQ: ETFC) from Neutral to Buy, and raised the price target from $13.50 to $19.00. In the report, Goldman Sachs noted, “We upgrade ETFC to Buy from Neutral with a 12-...

In a report published Tuesday, Goldman Sachs analyst Alexander Blostein downgraded NASDAQ OMX Group (NASDAQ: NDAQ) from Neutral to Sell, and lowered the price target from $30.00 to $28.00. In the report, Goldman Sachs noted, “We downgrade NDAQ to Sell from Neutral, with a $28 12-mo. price...

In a report published on Tuesday, Goldman Sachs analyst Alexander Blostein upgraded TD Ameritrade (NYSE: AMTD) from Sell to Neutral and raised the price target on the company from $19 to $27. In the report, Goldman Sachs stated, "Although we still think a majority of rate-related benefits are...

In a report published Monday, Goldman Sachs analyst Alexander Blostein upgraded the rating on CBOE Holdings (NASDAQ: CBOE) from Neutral to Buy, and reiterated the $47.00 price target. In the report, Goldman Sachs noted, “We upgrade shares of CBOE to Buy from Neutral with a 12% total return...

In a report published Monday, Goldman Sachs analyst Alexander Blostein upgraded the rating on CME Group (NASDAQ: CME) from Sell to Neutral, and raised the price target from $50.00 to $70.00. In the report, Goldman Sachs noted, “We upgrade shares of CME to Neutral from Sell. Despite the stock's...

Goldman Sachs analysts Marc Irizarry, Alexander Blostein and Neha Killa reiterated their Sell rating for shares of Federated Investors, Inc. (NYSE: FII). The analysts wrote that they see Federated Investors as a cyclical donor in the asset management business. They also said that Federated...